Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.
about
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.Adaptive immunity to fungi.Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophagesAntibody immunity and invasive fungal infectionsA 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis.Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infectionMolecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.Natural killer cells and antifungal host response.Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization.Natural killer cells mediate protection induced by a Salmonella aroA mutant.Killing of Cryptococcus neoformans strains by human neutrophils and monocytes.Protective murine monoclonal antibodies to Cryptococcus neoformansHuman natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharideCryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Antifungal activity of a human antiglucuronoxylomannan antibody.Expression of antibodies directed to Paracoccidioides brasiliensis glycosphingolipids during the course of paracoccidioidomycosis treatment.Natural Killer Cells in Antifungal Immunity.NK Cells and Their Role in Invasive Mold Infection.Adaptive Immunity to Cryptococcus neoformans Infections.
P2860
Q33751411-0CD9C31C-E0D6-4C92-8DAB-8E218B16130AQ33754371-FCBAEB0D-8C77-4135-A414-4FFBDA835F72Q35115708-6A48FF6F-444F-4EB6-A9F4-0D0283A70518Q35164257-8CAFAAF8-50A6-43A9-8186-8D976A8B3B57Q35386000-AD7E523E-B354-4FAD-A7AC-68E443630D4DQ35447692-01E24C63-0515-4668-B770-B0FEAF0092CFQ35546266-5EBAE0ED-AAF0-4221-98E8-23994F7CE63AQ35775466-EB95C295-B467-457C-AA18-C221C15DFF95Q36230201-C343464C-2874-4102-8825-3DBD6320400EQ36255421-2EB9E465-494F-45C3-9550-71A6E99EC0D1Q36361541-EEC4B00C-313A-4DCD-98F9-06D63D748926Q36456615-202084BF-C1FF-4F4C-B5EB-719676A0B5E3Q36757854-3A340D4D-3FA6-4211-A8E4-9C496C973657Q36950530-FC6B44AC-C610-4929-821F-FA9C4273602AQ36955180-37C629EC-E956-4EAC-8A02-2F081CC570C6Q36958548-2960D16E-DA8F-4B89-92C3-053FFC2903BCQ36969771-7B27F198-F9F3-4F3A-8934-C2B06B4182ECQ36978068-B3599A17-FB1C-48EC-957A-E9CF0C73011EQ36980669-60D8A794-D4F4-417F-ABB4-A732A72FD003Q36984524-5C57871C-7261-4BCE-B77A-929CB7B23766Q36988205-E1B578A0-0D8B-44F7-8F6A-03FB286178FBQ36999560-F942D942-3731-40DE-BCD5-07C4A2CB6AE1Q37017360-79C8234F-E3A8-4727-B916-0FA081A43A3EQ38011299-44F33271-5FB8-491E-A0C6-BA8E530ED333Q39630861-DC4C0429-E0C6-4231-9321-DBE5BCF81F1CQ42956726-B845A5D1-AA58-41C1-B556-F67BC59B55B5Q46246454-91C78067-C52B-41AF-85F1-4A7D92C21919Q49164976-6B1DF7F8-FC3D-4A15-AC33-48FAAF77D718Q49188733-26EBAB0E-6832-4548-A60A-CF3FB5CF7BD6
P2860
Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Antibody-dependent natural kil ...... on of Cryptococcus neoformans.
@en
type
label
Antibody-dependent natural kil ...... on of Cryptococcus neoformans.
@en
prefLabel
Antibody-dependent natural kil ...... on of Cryptococcus neoformans.
@en
P2860
P1476
Antibody-dependent natural kil ...... on of Cryptococcus neoformans.
@en
P2093
P2860
P304
P407
P577
1986-02-01T00:00:00Z